MoneyWorks4Me

A fair growth of 13.42% in the revenue at Rs. 24340.00 millions was reported in the September 2024 quarter as compared to Rs. 21460.00 millions during year-ago period.Net Profit recorded in the quarter ended September 2024 rise to 40.67% to Rs. 4600.00  millions  compared to R. 3270.00 millions in corresponding previous quarter.Operating profit surged to 9140.00 millions from the corresponding previous quarter of 7510.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 24340.00 21460.00 13.42 48720.00 42670.00 14.18 85330.00 76950.00 10.89
Other Income -70.00 150.00 -146.67 140.00 260.00 -46.15 910.00 820.00 10.98
PBIDT 9140.00 7510.00 21.70 18340.00 14990.00 22.35 29810.00 25470.00 17.04
Interest 540.00 770.00 -29.87 1180.00 1670.00 -29.34 3030.00 2980.00 1.68
PBDT 8600.00 6740.00 27.60 17160.00 13320.00 28.83 26780.00 22490.00 19.08
Depreciation 1900.00 1920.00 -1.04 3790.00 3750.00 1.07 7610.00 6720.00 13.24
PBT 6700.00 4820.00 39.00 13370.00 9570.00 39.71 19170.00 15770.00 21.56
TAX 2100.00 1550.00 35.48 4080.00 3070.00 32.90 5600.00 5250.00 6.67
Deferred Tax 710.00 720.00 -1.39 1520.00 1420.00 7.04 2380.00 2510.00 -5.18
PAT 4600.00 3270.00 40.67 9290.00 6500.00 42.92 13570.00 10520.00 28.99
Equity 1692.30 1692.30 0.00 1692.30 1692.30 0.00 1692.30 1692.30 0.00
PBIDTM(%) 37.55 35.00 7.30 37.64 35.13 7.16 34.93 33.10 5.55
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..